DNAnexus Secures $15,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    420 Florence St. Palo Alto, CA 94301
  • Company Description
    DNAnexus is a start-up in biocomputation aiming to transform the future of genetics, alter the course of medicine, help cure cancer! The advent of next-generation DNA sequencing technologies will soon enable one of the holy grails of medicine: the personal genome.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    The new capital will help further DNAnexus’ mission to unlock the potential of DNA-based medicine and biotechnology by creating scalable and collaborative data technologies. The company intends to use the funds to expand hiring and accelerate product development.
  • M&A Terms
  • Venture Investor
    TPG Biotech
  • Venture Investor
    Google Ventures
  • Venture Investor
    SoftTech VC
  • Venture Investor
    K9 Ventures
  • Venture Investor
    First Round Capital
  • Venture Investor
    Felicis Ventures

Trending on Xconomy